Semaglutide and Muscle Protein Synthesis: What Patients Need to Know

Written by Adam Maggio | Medically reviewed by Dr. James Whitfield, DO, FACOI

Patients on semaglutide often experience lean mass reduction alongside fat loss, a common outcome of significant weight reduction. However, semaglutide may also improve muscle metabolic efficiency; prioritizing high protein intake and resistance exercise is crucial to mitigate muscle loss and optimize body composition.

Patients often express concern about muscle loss when starting semaglutide, and for good reason: significant weight reduction, regardless of method, typically involves some degree of lean mass decrease. This isn't unique to GLP-1 agonists, but it's a critical consideration for anyone undergoing rapid weight loss.

Clinical observations consistently show that individuals losing substantial weight on semaglutide experience a reduction in lean body mass alongside fat mass. For instance, the interim results from the COURAGE trial, reported by Regeneron (2025), indicated that approximately 35% of semaglutide-induced weight loss was attributable to lean mass. Similarly, Jamialahmadi et al. (2025) noted that semaglutide-induced weight loss is linked to decreases in both lean and fat mass. This phenomenon arises because when the body is in a significant caloric deficit, it can catabolize muscle tissue for energy, especially if protein intake is insufficient. This catabolism is a natural physiological response to energy scarcity, where the body taps into its protein reserves to fuel essential functions.

However, the picture isn't entirely straightforward. Unlike simple caloric restriction, semaglutide, as a GLP-1 receptor agonist, might also exert direct or indirect effects on muscle tissue. Research by Jeromson et al. (2025) found that semaglutide upregulated the expression of Eef2 and Igf1r, genes associated with protein translation and muscle size. This suggests a potential for semaglutide to influence muscle protein synthesis pathways, even amidst overall weight loss. The upregulation of Eef2 (eukaryotic elongation factor 2) is particularly interesting, as it plays a crucial role in the elongation phase of protein synthesis, indicating a potential for enhanced muscle repair and growth signaling. Furthermore, Choi et al. (2025) observed that semaglutide improved skeletal muscle OXPHOS efficiency, meaning the mitochondria in muscle cells became more efficient at producing ATP, the body's energy currency. This enhanced mitochondrial function could translate to better muscle endurance and overall metabolic health, even if muscle mass is slightly reduced.

So, what does this clinical nuance mean for patients? While the overall reduction in lean mass is a reality of significant weight loss, these findings hint that semaglutide might simultaneously be improving the metabolic quality or efficiency of the remaining muscle. It's a complex interplay: the drug facilitates weight loss, which can lead to muscle catabolism, yet it may also offer some protective or enhancing effects at a cellular level. This is a crucial distinction, as preserving muscle function and quality is just as important as preserving mass. We're not just looking at the quantity of muscle, but its functional capacity and metabolic health.

To actively mitigate muscle loss, specific interventions are highly effective. The Endocrine Society (Haines, 2025) highlighted that higher protein intake can help prevent muscle loss, particularly in women and older adults taking anti-obesity drugs. We typically recommend aiming for 1.2 to 1.6 grams of protein per kilogram of body weight daily. This provides the necessary amino acid building blocks for muscle repair and synthesis. For a 180-pound individual, this translates to roughly 98-130 grams of protein per day. Unlike simply reducing calories, strategic protein intake ensures the body has ample resources to maintain and even build muscle while in a caloric deficit. Additionally, regular resistance exercise is paramount. As Mass General (2025) emphasized, patients who engage in consistent exercise from the start of treatment have the best chances of preserving lean body mass and improving body composition. This includes activities like weightlifting, bodyweight exercises, or resistance band training, performed 2-3 times per week.

It's also important to consider the timing of protein intake. Spreading protein consumption throughout the day, rather than consuming it all in one or two large meals, can optimize muscle protein synthesis. For example, incorporating a protein source with each meal and a protein shake post-workout can be highly beneficial. Furthermore, adequate hydration and sufficient sleep play supportive roles in muscle recovery and overall metabolic health, complementing the effects of diet and exercise.

For patients on semaglutide, prioritizing resistance training and ensuring a high-protein diet—aiming for 1.2-1.6g/kg of body weight daily—is crucial to preserve muscle mass and optimize body composition during weight loss. Don't just focus on the number on the scale; focus on maintaining strength, vitality, and the functional integrity of your musculature. This proactive approach ensures that weight loss is healthy and sustainable, leading to improved long-term outcomes.